Patents by Inventor Gere S. DiZerega

Gere S. DiZerega has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140205631
    Abstract: The present invention provides angiotensin peptide compositions and methods for use of the compositions in vaccination.
    Type: Application
    Filed: January 21, 2014
    Publication date: July 24, 2014
    Inventors: Robert LARSEN, Kathleen E. RODGERS, Gere S. DIZEREGA
  • Publication number: 20140031286
    Abstract: The present invention provides angiotensin (1-7) pharmaceutical compositions, dosage forms, and methods for their use, and methods for treating or limiting development of acquired immune deficiency syndrome.
    Type: Application
    Filed: September 10, 2013
    Publication date: January 30, 2014
    Applicant: UNIVERSITY OF SOUTHERN CALIFORNIA
    Inventors: Kathleen E. Rodgers, Gere S. DiZerega
  • Patent number: 8536231
    Abstract: The present invention provides methods and pharmaceutical formulations for treating diabetic foot ulcers.
    Type: Grant
    Filed: May 9, 2012
    Date of Patent: September 17, 2013
    Inventors: Kathleen E. Rodgers, Gere S. diZerega
  • Publication number: 20130230485
    Abstract: The present invention provides methods for treating a patient undergoing multi-cycle chemotherapy that provides significantly improved platelet counts in the patients, and facilitates retention of dose intensity from cycle to cycle of the chemotherapy.
    Type: Application
    Filed: February 28, 2013
    Publication date: September 5, 2013
    Inventors: Kathleen E. Rodgers, Gere S. diZerega
  • Publication number: 20130123190
    Abstract: The present invention provides methods for treating a subject that has suffered combined exposure to total body ionizing irradiation and burns.
    Type: Application
    Filed: March 28, 2011
    Publication date: May 16, 2013
    Applicant: UNIVERSITY OF SOUTHERN CALIFORNIA
    Inventors: Kathleen E. Rodgers, Gere S. diZerega
  • Publication number: 20120329729
    Abstract: The present invention provides methods and pharmaceutical formulations for treating diabetic foot ulcers.
    Type: Application
    Filed: May 9, 2012
    Publication date: December 27, 2012
    Applicant: UNIVERSITY OF SOUTHERN CALIFORNIA
    Inventors: Kathleen E. Rodgers, Gere S. diZerega
  • Patent number: 8207234
    Abstract: The present invention provides methods and pharmaceutical formulations for treating diabetic foot ulcers.
    Type: Grant
    Filed: April 6, 2012
    Date of Patent: June 26, 2012
    Assignee: University of Southern California
    Inventors: Kathleen E. Rodgers, Gere S. diZerega
  • Patent number: 8207233
    Abstract: The present invention provides methods and pharmaceutical formulations for treating diabetic foot ulcers.
    Type: Grant
    Filed: February 1, 2012
    Date of Patent: June 26, 2012
    Assignee: University of Southern California
    Inventors: Kathleen E. Rodgers, Gere S. diZerega
  • Publication number: 20120071397
    Abstract: The present invention provides methods for treating a subject undergoing hematopoietic stem cell transplantation, methods for increasing a subject's resistance to bacterial or viral infection during and/or following hematopoietic stem cell transplantation, and methods for treating norovirus infection.
    Type: Application
    Filed: August 10, 2011
    Publication date: March 22, 2012
    Applicant: University of Southern California
    Inventors: Kathleen E. Rodgers, Gere S. diZerega
  • Publication number: 20090227507
    Abstract: The present invention provides angiotensin (1-7) pharmaceutical compositions, dosage forms, and methods for their use, and methods for treating or limiting development of acquired immune deficiency syndrome.
    Type: Application
    Filed: March 9, 2009
    Publication date: September 10, 2009
    Applicant: UNIVERSITY OF SOUTHERN CALIFORNIA
    Inventors: Kathleen E. Rodgers, Gere S. DiZerega
  • Publication number: 20090069246
    Abstract: The present invention provides methods, improved cell culture medium and kits for promoting hematopoietic and mesenchymal stem and lineage-specific cell proliferation and differentiation by growth in the presence of angiotensinogen, angiotensin I (AI), AI analogues, AI fragments and analogues thereof, angiotensin II (AII), AII analogues, AII fragments or analogues thereof or AII AT2 type 2 receptor agonists, either alone or in combination with other growth factors and cytokines.
    Type: Application
    Filed: May 26, 2006
    Publication date: March 12, 2009
    Applicant: University of Southern California
    Inventors: Kathleen E. Rodgers, Gere S. diZerega
  • Publication number: 20080167252
    Abstract: The present invention provides improved methods, kits, and pharmaceutical compositions for increasing hematopoietic cell survival and/or reducing or preventing the side effects of chemotherapy, and mobilizing hematopoietic progenitor cells from bone marrow into peripheral blood following chemotherapy, comprising administering an effective amount of angiotensinogen, angiotensin I (AI), AI analogues, AI fragments and analogues thereof, angiotensin II (AII), AII analogues, AII fragments or analogues thereof or AII AT2 type 2 receptor agonists to a patient in need of chemotherapy.
    Type: Application
    Filed: January 11, 2008
    Publication date: July 10, 2008
    Inventors: Kathleen E. Rodgers, Gere S. DiZerega
  • Patent number: 7176183
    Abstract: The present invention provides improved methods, kits, and pharmaceutical compositions for treating and preventing damage to mucosal tissue by administering an effective amount of angiotensinogen, angiotensin I (AI), AI analogues, AI fragments and analogues thereof, angiotensin II (AII), AII analogues, AII fragments or analogues thereof or AII AT2 type 2 receptor agonists to the subject.
    Type: Grant
    Filed: June 23, 2004
    Date of Patent: February 13, 2007
    Assignee: University of Southern California
    Inventors: Kathleen E. Rodgers, Gere S. diZerega
  • Patent number: 7122523
    Abstract: The present invention provides methods, compounds, and pharmaceutical compositions for inhibiting tumor cell proliferation, by administering an effective amount of angiotensinogen, angiotensin I (AI), AI analogues, AI fragments and analogues thereof, angiotensin II (AII), AII analogues, AII fragments or analogues thereof or AII AT2 type 2 receptor agonists to a subject.
    Type: Grant
    Filed: April 26, 2002
    Date of Patent: October 17, 2006
    Assignee: University of Southern California
    Inventors: Kathleen E. Rodgers, Gere S. diZerega
  • Patent number: 7118748
    Abstract: The present invention provides methods, improved cell culture medium and kits for promoting hematopoietic and mesenchymal stem and lineage-specific cell proliferation and differentiation by growth in the presence of angiotensinogen, angiotensin I (Al), AI analogues, AI fragments and analogues thereof, angiotensin II (AII), AII analogues, AII fragments or analogues thereof or AII AT2 type 2 receptor agonists, either alone or in combination with other growth factors and cytokines.
    Type: Grant
    Filed: May 3, 2000
    Date of Patent: October 10, 2006
    Assignee: University of Southern California
    Inventors: Kathleen E. Rodgers, Gere S. diZerega
  • Patent number: 7022675
    Abstract: Methods and compositions based on chemical analogs of angiotensin II and analogs of angiotensin II fragments useful for accelerating wound healing in mammals.
    Type: Grant
    Filed: August 6, 2002
    Date of Patent: April 4, 2006
    Assignee: University of Southern California
    Inventors: Kathleen E. Rodgers, Gere S. DiZerega
  • Patent number: 6916783
    Abstract: The present invention provides improved methods, kits, and compositions for enhancing bone, cartilage and cartilage repair, bone and prosthesis implantation, and attachment and fixation of cartilage and cartilage to bone or other tissues, and chondrocyte proliferation composing the administration of an effective amount of angiotensinogen, angiotensin I (AI), AI analogues, AI fragments and analogues thereof, angiotensin II (AII), AII analogues, AII fragments or analogues thereof or AII AT2 type 2 receptor agonists.
    Type: Grant
    Filed: January 30, 2001
    Date of Patent: July 12, 2005
    Assignee: University of Southern California
    Inventors: Kathleen E. Rodgers, Gere S. DiZerega
  • Publication number: 20040176302
    Abstract: The present invention provides methods, compounds, and pharmaceutical compositions for inhibiting tumor cell proliferation, by administering an effective amount of angiotensinogen, angiotensin I (AI), AI analogues, AI fragments and analogues thereof, angiotensin II (AII), AII analogues, AII fragments or analogues thereof or AII AT2 type 2 receptor agonists to a subject.
    Type: Application
    Filed: April 26, 2002
    Publication date: September 9, 2004
    Inventors: Kathleen E. Rodgers, Gere S. diZerega
  • Patent number: 6762167
    Abstract: The present invention provides improved methods, kits, and pharmaccutical compositions for increasing hematopoietic cell survival and/or reducing or preventing the side effects of chemotherapy, and mobilizing hematopoietic progenitor cells from bone marrow into peripheral blood following chemotherapy, comprising administering an effective amount of angiotensinogen, angiotensin I (AI), AI analogues, AI fragments and analogues thereof, angiotensin II (AII), AII analogues. AII fragments or analogues thereof or AII AT2 type 2 receptor agonists to a patient in need of chemotherapy.
    Type: Grant
    Filed: November 27, 2000
    Date of Patent: July 13, 2004
    Assignee: University of Southern California
    Inventors: Kathleen E. Rodgers, Gere S. DiZerega
  • Patent number: 6747008
    Abstract: The present invention provides improved methods, kits, and pharmaceutical compositions for treating and preventing alopecia in a subject in need thereof by administering an effective amount of angiotensinogen, angiotensin I (AI), AI analogues, AI fragments and analogues thereof, angiotensin II (AII), AII analogues, AII fragments or analogues thereof or AII AT2 type 2 receptor agonists to the subject.
    Type: Grant
    Filed: November 27, 2000
    Date of Patent: June 8, 2004
    Assignee: University of Southern California
    Inventors: Kathleen E. Rodgers, Gere S. DiZerega